Literature DB >> 21191472

Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers.

Maki Inoue-Choi1, Jian-Min Yuan, Chung S Yang, David J Van Den Berg, Mao-Jung Lee, Yu-Tang Gao, Mimi C Yu.   

Abstract

Available in vitro and animal studies have shown cancer protective effects of tea polyphenols. Recent study suggests a greater protective effect of green tea intake on breast cancer risk among women possessing the low-activity associated genotype of the catechol-O-methyltransferase (COMT), which may modulate the metabolism and excretion of tea polyphenols through urine. To determine the effect of COMT genotype on urinary excretion of tea polyphenol metabolites of daily green tea drinkers, a cross-sectional analysis was performed within the Shanghai Cohort Study, a population-based, prospective investigation of diet and cancer in 18,244men. In addition to an in-person interview, each participant provided a blood and urine sample at baseline. In the present study, COMT genotype (rs4680) and five urinary metabolites of tea polyphenols were determined in 660 cohort subjects who self-identified as daily drinkers of green tea. All urinary tea polyphenol measurements were expressed in units of urinary creatinine. Men possessing the homozygous low-activity associated COMT genotype (LL) exhibited statistically significantly lower urinary levels of individual as well as all of the five tea polyphenol metabolites under study relative to individuals possessing the wild type high-activity associated COMT genotype (HH)or the heterozygous variant genotype (HL). Levels of urinary tea polyphenol metabolites were comparable between men possessing the HH and HL genotypes. The present study demonstrated that men carrying low-activity associated COMT genotype excreted less tea polyphenols from urine, which suggests that they may retain more tea polyphenols in their bodies and derive greater health benefits from green tea intake.

Entities:  

Year:  2010        PMID: 21191472      PMCID: PMC3010377     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  32 in total

Review 1.  Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase.

Authors:  R M Weinshilboum; D M Otterness; C L Szumlanski
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Inhibitors of catecholamine metabolizing enzymes cause changes in S-adenosylmethionine and S-adenosylhomocysteine in the rat brain.

Authors:  M S Yassin; H Cheng; J Ekblom; L Oreland
Journal:  Neurochem Int       Date:  1998-01       Impact factor: 3.921

3.  Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.

Authors:  S Dawling; N Roodi; R L Mernaugh; X Wang; F F Parl
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

4.  Prospective evaluation of dietary and other predictors of fatal stroke in Shanghai, China.

Authors:  R K Ross; J M Yuan; B E Henderson; J Park; Y T Gao; M C Yu
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

5.  An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.

Authors:  J A Lavigne; K J Helzlsouer; H Y Huang; P T Strickland; D A Bell; O Selmin; M A Watson; S Hoffman; G W Comstock; J D Yager
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

6.  On the role of O-methylation in the metabolism of S-adenosylmethionine in rat brain.

Authors:  P C Waldmeier; J J Feldtrauer
Journal:  Biochem Pharmacol       Date:  1987-09-01       Impact factor: 5.858

7.  Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.

Authors:  R K Ross; J M Yuan; M C Yu; G N Wogan; G S Qian; J T Tu; J D Groopman; Y T Gao; B E Henderson
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

8.  Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study.

Authors:  J M Yuan; R K Ross; X L Wang; Y T Gao; B E Henderson; M C Yu
Journal:  JAMA       Date:  1996-06-05       Impact factor: 56.272

9.  Tea intake, COMT genotype, and breast cancer in Asian-American women.

Authors:  Anna H Wu; Chiu-Chen Tseng; David Van Den Berg; Mimi C Yu
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

10.  Influence of drinking green tea on breast cancer malignancy among Japanese patients.

Authors:  K Nakachi; K Suemasu; K Suga; T Takeo; K Imai; Y Higashi
Journal:  Jpn J Cancer Res       Date:  1998-03
View more
  25 in total

1.  Cancer prevention by green tea: evidence from epidemiologic studies.

Authors:  Jian-Min Yuan
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

Review 2.  Tea and cancer prevention: epidemiological studies.

Authors:  Jian-Min Yuan; Canlan Sun; Lesley M Butler
Journal:  Pharmacol Res       Date:  2011-03-23       Impact factor: 7.658

3.  Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer.

Authors:  Hamed Samavat; Anna H Wu; Giske Ursin; Carolyn J Torkelson; Renwei Wang; Mimi C Yu; Douglas Yee; Mindy S Kurzer; Jian-Min Yuan
Journal:  J Nutr       Date:  2019-04-01       Impact factor: 4.798

4.  Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.

Authors:  Katherine D Crew; Powel Brown; Heather Greenlee; Therese B Bevers; Banu Arun; Clifford Hudis; Heather L McArthur; Jenny Chang; Mothaffar Rimawi; Lana Vornik; Terri L Cornelison; Antai Wang; Hanina Hibshoosh; Aqeel Ahmed; Mary Beth Terry; Regina M Santella; Scott M Lippman; Dawn L Hershman
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-24

5.  Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo.

Authors:  Piwen Wang; David Heber; Susanne M Henning
Journal:  Food Funct       Date:  2012-06       Impact factor: 5.396

Review 6.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

7.  Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.

Authors:  Piwen Wang; Jaydutt V Vadgama; Jonathan W Said; Clara E Magyar; Ngan Doan; David Heber; Susanne M Henning
Journal:  J Nutr Biochem       Date:  2013-10-10       Impact factor: 6.048

8.  Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells.

Authors:  Piwen Wang; David Heber; Susanne M Henning
Journal:  Nutr Cancer       Date:  2012-03-27       Impact factor: 2.900

9.  The catechol-O-methyltransferase inhibitor, tolcapone, increases the bioavailability of unmethylated (-)-epigallocatechin-3-gallate in mice.

Authors:  Sarah C Forester; Joshua D Lambert
Journal:  J Funct Foods       Date:  2015-08-01       Impact factor: 4.451

10.  Green and black tea intake in relation to prostate cancer risk among Singapore Chinese.

Authors:  Julia A Montague; Lesley M Butler; Anna H Wu; Jeanine M Genkinger; Woon-Puay Koh; Alvin S Wong; Renwei Wang; Jian-Min Yuan; Mimi C Yu
Journal:  Cancer Causes Control       Date:  2012-08-03       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.